Ravenquest Biomed Ownership

Ravenquest Biomed owns a total of 123.62 Million outstanding shares. Ravenquest Biomed holds 10.51 pct. of its outstanding shares held by insiders and 3.22 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Ravenquest Biomed in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Ravenquest Biomed, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ravenquest Biomed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

Ravenquest Pink Sheet Ownership Analysis

The company has price-to-book ratio of 0.03. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Ravenquest Biomed recorded a loss per share of 0.22. The entity had not issued any dividends in recent years. RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada. RAVENQUEST BIOMED operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange.The quote for Ravenquest Biomed is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Ravenquest Biomed contact George Robinson at 877-282-1586 or learn more at https://www.rqbglobal.com.

Ravenquest Biomed Outstanding Bonds

Ravenquest Biomed issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ravenquest Biomed uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ravenquest bonds can be classified according to their maturity, which is the date when Ravenquest Biomed has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in Ravenquest Pink Sheet

Ravenquest Biomed financial ratios help investors to determine whether Ravenquest Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ravenquest with respect to the benefits of owning Ravenquest Biomed security.